EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.4.1 | Campylobacter jejuni | - |
- |
- |
2.7.4.1 | Campylobacter jejuni 81-176 | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.4.1 | ATP + (phosphate)n | - |
Campylobacter jejuni | ADP + (phosphate)n+1 | - |
? | |
2.7.4.1 | ATP + (phosphate)n | - |
Campylobacter jejuni 81-176 | ADP + (phosphate)n+1 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.4.1 | poly-P kinase 1 | - |
Campylobacter jejuni |
2.7.4.1 | PPK1 | - |
Campylobacter jejuni |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.4.1 | ATP | - |
Campylobacter jejuni |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.4.1 | malfunction | ppk1-knockout mutant is deficient in poly-P accumulation, which is associated with a decreased ability to form viable-but-nonculturable cells under acid stress. The ppk1-deficient mutant shows a significant increase in susceptibility to erythromycin, cefotaxime, ciprofloxacin, rifampin, polymyxin B, tetracycline, cholic acid, taurocholic acid, deoxycholic acid, ethidium bromide, and SDS | Campylobacter jejuni |